China NT Pharma Group Company Limited (HKG:1011)
Hong Kong · Delayed Price · Currency is HKD 0.5400
-0.0200 (-3.57%)
Jun 1, 2026, 3:58 PM HKT
HKG:1011 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -26.04 | -53.36 | -143.59 | -66.41 | -149.54 |
Depreciation & Amortization | 0.64 | 0.66 | 5.55 | 20.65 | 41.82 |
Other Amortization | - | - | 0.33 | 5.53 | 0.43 |
Loss (Gain) From Sale of Assets | - | 7.01 | -12.29 | - | -41.04 |
Asset Writedown & Restructuring Costs | - | 0.12 | 0.01 | 0.08 | - |
Loss (Gain) From Sale of Investments | -14.08 | 5.92 | - | 0.63 | 6.04 |
Loss (Gain) on Equity Investments | - | -10.24 | -37.04 | -9 | -34.49 |
Stock-Based Compensation | - | - | - | 0.6 | 0.08 |
Provision & Write-off of Bad Debts | - | - | 1.66 | 0.25 | 9.74 |
Other Operating Activities | 27.76 | 37.68 | 160.82 | 100.33 | 124.23 |
Change in Accounts Receivable | -1.28 | -1 | 67.33 | -32.11 | 7.94 |
Change in Inventory | -0.23 | -0.17 | -2.53 | 19.88 | -5.19 |
Change in Accounts Payable | 7.84 | 4.31 | 16.72 | -1.03 | -94.81 |
Change in Other Net Operating Assets | - | - | - | 1.06 | -0.56 |
Operating Cash Flow | -5.39 | -9.07 | 50.48 | 36.21 | -135.34 |
Operating Cash Flow Growth | - | - | 39.40% | - | - |
Capital Expenditures | -0.16 | -0.18 | -10.73 | -4.49 | -0.65 |
Sale of Property, Plant & Equipment | - | - | 0.16 | - | 32.56 |
Cash Acquisitions | - | - | - | - | -4.97 |
Divestitures | - | -0.02 | -0.2 | - | 438.71 |
Sale (Purchase) of Intangibles | - | - | -2.16 | - | - |
Investment in Securities | - | - | - | 9 | -232.59 |
Other Investing Activities | 0.01 | 0.01 | -9.21 | 0.02 | 24.76 |
Investing Cash Flow | -0.15 | -0.19 | -22.14 | 4.53 | 257.81 |
Long-Term Debt Issued | 34.37 | 30.67 | 18.08 | 53.38 | 83.22 |
Total Debt Issued | 34.37 | 30.67 | 18.08 | 53.38 | 83.22 |
Long-Term Debt Repaid | -9.61 | -8.03 | -37.2 | -82.38 | -164.69 |
Total Debt Repaid | -9.61 | -8.03 | -37.2 | -82.38 | -164.69 |
Net Debt Issued (Repaid) | 24.76 | 22.64 | -19.12 | -29 | -81.47 |
Issuance of Common Stock | - | - | 9.39 | 2.02 | - |
Other Financing Activities | -19.89 | -9.99 | -19.24 | -19.7 | -43.33 |
Financing Cash Flow | 4.87 | 12.65 | -28.97 | -46.68 | -124.8 |
Foreign Exchange Rate Adjustments | -1.73 | 4.71 | 0.24 | 3.49 | 3.37 |
Net Cash Flow | -2.4 | 8.1 | -0.4 | -2.45 | 1.05 |
Free Cash Flow | -5.55 | -9.24 | 39.74 | 31.72 | -135.98 |
Free Cash Flow Growth | - | - | 25.31% | - | - |
Free Cash Flow Margin | -22.96% | -24.35% | 539.55% | - | -59.98% |
Free Cash Flow Per Share | -0.01 | -0.04 | 0.17 | 0.17 | -0.72 |
Cash Interest Paid | 19.89 | 9.99 | 18.77 | 17.57 | 42.86 |
Cash Income Tax Paid | - | - | 0.86 | 1.04 | 0.8 |
Levered Free Cash Flow | -78.97 | 10.18 | 14.34 | 238.01 | 159.33 |
Unlevered Free Cash Flow | -61.57 | 29.89 | 32.36 | 262.61 | 214.78 |
Change in Working Capital | 6.33 | 3.15 | 81.52 | -12.19 | -92.62 |